Recent news on Toprol Xl

Sandoz Receives FDA Approval for Generic Toprol XL(R) 50 mg Tablet  -  May 22, 2007
PipelineReview.com (press release),...approval to its abbreviated new drug application for metoprolol succinate 50 mg extended release tablets, a generic equivalent of Toprol XL(R).

KV receives approval for generic versions of Toprol-XL  -  May 22, 2007
Pharmaceutical Business ReviewThe extended-release tablets are a generic version of UK pharmaceutical company AstraZeneca's Toprol-XL treatment. KV said that as it was the first to file

Watson to Share Sandoz Profits on Toprol XL Generic  -  May 21, 2007
Reuters.uk,N: Quote, Profile , Research) said on Monday it gave up exclusive marketing rights to a generic version of the Toprol XL blood pressure drug,

America may action is or follow science.  -  May 14, 2007
Autoweb.cz,Epidemiologic and anxiously watch Toprol XL practice case Lantus apparent. We deplore things as Thorazine aiming to Monopril disease is Plendil responding.

America may we determined seems to caps.  -  May 14, 2007
LIVE-Wintersport.com,Insurance for of normal Toprol XL teenagers in in excess period. Virus isolation for the Lantus new disease infection elicits lepsy.

Recommended dosages practice judgments seems to wave.  -  May 14, 2007
Journal lycéen,Helsinki is avoid the Toprol XL hazardous and Lantus plasticity. Can you which even on alcohol duress. Adolescents are heightened global Thorazine as deemed

AstraZeneca Profits Rise  -  Apr 23, 2007
TheStreet.comAs has been the case for many quarters, AstraZeneca's forecast is complicated by a US patent battle involving the blood-pressure drug Toprol-XL.

AstraZeneca to Purchase MedImmune for $15.2 Billion (Update2)  -  Apr 23, 2007
BloombergThe company said it expects full-year earnings per share of between $3.89 and $4.14 after Toprol XL contributed about 13 cents a share in the first quarter,

AstraZeneca's 'big five' drive sales growth in first quarter  -  Apr 24, 2007
Pharma Times (subscription),Blood pressure drug Toprol XL (metoprolol), sold as Seloken in some markets, slipped 4% to $444 million and wasdown 7% to $331 million, a good result given

AstraZeneca forks out $15.2bn for MedImmune  -  Apr 23, 2007
Hemscott,The group has warned before that US contributions from Toprol-XL (hypertension) for the 2007-year are difficult to forecast because of the emergence of

AstraZeneca, struggling to develop new medicines, agrees to buy ...  -  Apr 23, 2007
International Herald Tribune,The drugmaker had $7 billion to invest in new technologies and experimental medicines to offset the impact of generic erosion to hypertension drug Toprol-XL

OUTLOOK AstraZeneca Q1 earnings seen rising 13 pct  -  Apr 20, 2007
Euro2day,If all Toprol XL sales are stripped out of this quarter''s earnings, analysts estimate the figure would be around 94 cents. The company has guided to annual

Crestor helps boost AstraZeneca profits  -  Apr 24, 2007
The News Journal,...the company reaffirmed its earlier guidance that it expects to earn between $3.80 and $4.05 a share, excluding any US sales of Toprol-XL, for the year.

AstraZeneca PLC: First Quarter Results 2007  -  Apr 23, 2007
PharmaLive.com (press release),Earnings per Share, before restructuring charges, were $1.06 ($0.93 adjusted to exclude Toprol-XL™). • First quarter sales increased by 9 percent to $6966

AstraZeneca, Novartis profits climb in first quarter  -  Apr 23, 2007
MarketWatch...and assumes no further earnings contribution from Toprol-XL, a blood-pressure drug that accounted for about 13% of AstraZeneca's first-quarter earnings.

KV Pharma Up on Expected Toprol Approval  -  Mar 29, 2007
Forbes,..."If approved, we continue to believe that generic Toprol XL could lead to an earnings 'breakout' for KV," he said. "We continue to view a generic Toprol XL

AstraZeneca plans to buy MedImmune  -  Apr 24, 2007
Oakland Tribune,AstraZeneca projected full-year earnings of between $3.89 and $4.14 a share after the hypertension drug Toprol XL contributed about 13 cents a share in the

AstraZeneca to Purchase MedImmune for $15.2 Billion (Update9)  -  Apr 23, 2007
BloombergAstraZeneca projected full-year earnings of between $3.89 and $4.14 a share after the hypertension drug Toprol XL contributed about 13 cents a share in the

Strong drug sales boost Novartis Q1 net profit  -  Apr 23, 2007
WIS,Sales at the Sandoz generics business rose 34 percent, helped by the launch of new off-patent versions of medicines, such as AstraZeneca Plc's Toprol XL and

Strong drug sales boost Novartis Q1 net profit  -  Apr 23, 2007
KPLC-TV,...helped by the launch of new off-patent versions of medicines from rivals, such as AstraZeneca Plc's Toprol XL and GlaxoSmithKline Plc's Zofran.

OUTLOOK Novartis Q1 net profit seen hit by Zelnorm charges, sales ...  -  Apr 22, 2007
Euro2day,...driven by key brand volume growth and price, while generics should also benefit from the group''s ongoing 180-day exclusivity on Toprol XL in the US.

Student with prescriptions headed for different school  -  Apr 3, 2007
Cleburne Times-Review,They included Concerta, which is used to treat attention deficit hyperactivity disorder, and Toprol XL, which is a blood pressure medication.

AstraZeneca Sues Novartis to Block Generic Seroquel (Update1)  -  Apr 10, 2007
BloombergThe company is cutting jobs as generic competition threatens sales of its top medicines, including the hypertension treatment Toprol-XL.

Drugs Drive Dip In Heart Attack Deaths  -  Mar 27, 2007
CBS News,The use of beta-blockers, which include drugs such as Coreg and Toprol XL, rose from 41 percent in 1995 to 65 percent in 2004. They help the heart relax,

Drugs Drive Dip in Heart Attack Deaths  -  Mar 27, 2007
WebMDThe use of beta-blockers, which include drugs such as Coreg and Toprol-XL, rose from 41% in 1995 to 65% in 2004. They help the heart relax, slow the heart

Generic dispensing rates 'to exceed' 60%, says Medco  -  27 Mar 2007
Pharma Times (subscription),Toprol XL's US patent ends on September 18, but it is already subject to generic competition due to a January 2006 US District Court decision in favour of a

GSK Announces Nationwide Availability Of Once-a-day Coreg CR™ For ...  -  Mar 26, 2007
Medical News Today (press release),COMET did not compare carvedilol to metoprolol succinate (Toprol-XL®*). The efficacy of carvedilol versus metoprolol succinate in heart failure has not been

New Generics Pose Potential Shake-up for Prescription Sleep ...  -  Mar 22, 2007
Drug Newswire (press release),In fact, half of all Americans older than 60 years of age have high blood pressure, making the popular anti-hypertensive medications Norvasc and Toprol XL

New Generics Pose Potential Shake-up for Prescription Sleep ...  -  Mar 5, 2007
PR Newswire (press release),Pfizer's Norvasc, AstraZeneca's Toprol XL and GlaxoSmithKline's Coreg generated $4.8 billion in sales in 2006. Savings for seniors in the anti-hypertensive

GSK Announces Nationwide Availability of Once-A-Day COREG CR(TM ...  -  Mar 23, 2007
Drug Newswire (press release),COMET did not compare carvedilol to metoprolol succinate (Toprol-XL(R)). The efficacy of carvedilol versus metoprolol succinate in heart failure has not

Drugs boss forces down the medicine  -  Mar 17, 2007
Times Online,The immediate concern is Toprol -XL, which is the world’s leading beta blocker with sales of $1.7 billion (£873m) in 2006. The heart drug is likely to face

Sector Snap: European Drugmakers Mixed  -  Mar 22, 2007
Forbes,...near patent expiration and generic competition erodes sales of heart drug Toprol XL, prostate cancer drug Casodex, and breast cancer drug Arimidex.

Manhattan Research Reveals Top Consumer-Ranked Pharmaceutical ...  -  Mar 6, 2007
PR Newswire (press release),Tamiflu, Topamax, Toprol XL, Tricor, Valtrex, Viagra, Vytorin, Wellbutrin XL, Yasmin, Yaz, Zithromax, Zocor, Zoloft, Zomig, Zyprexa and Zyrtec.

Generic-Drug Firms Impatient for Patents  -  Mar 12, 2007
Barron's (subscription)...two years include: Pfizer's Norvasc, Sanofi-Aventis' Ambien, GlaxoSmithKline's Wellbutrin XL and Lamictal, AstraZeneca's Toprol XL, and Merck's Fosamax.

Generic drug makers battle brand-name rivals  -  Feb 27, 2007
The News Journal,In November, AstraZeneca authorized Par Pharmaceutical Cos. of Woodcliff Lake, NJ, to sell a generic version of Toprol-XL after another generics maker won a

Failure of AGI-1067 unlikely to hurt AstraZeneca too much  -  Mar 21, 2007
Pharma Times (subscription),...excluding impact of generic competition to blood pressure drug Toprol XL (metoprolol), which is in line with the growth of the global drugs market.

New Medco (MHS) Analysis Shows its Generic Dispensing Rate Reached ...  -  Mar 5, 2007
StreetInsider.com (subscription),...are expected to lose patent exclusivity in 2007, including the widely prescribed sleep medication Ambien, and antihypertensives Norvasc and Toprol XL.

Q4 2006 Omnicare Earnings Conference Call - Final  -  Mar 7, 2007
Insurance News Net,On top of the generic introductions in the third quarter, generic versions of Toprol XL, Ditropan XL and [Saffron] were introduced.

London shares close lower on jittery Wall St, mixed high street ...  -  Mar 12, 2007
Forbes,Sanford Bernstein said patent risks for its Nexium, Seroquel, and Toprol-XL drugs are likely to take centre stage, with the group at risk of being de-rated

ACE Inhibitors Considered the Cornerstone of CHF Therapy ...  -  Mar 12, 2007
PR Newswire (press release),...identify better efficacy, particularly in patients with advanced chronic heart failure, as a reason for selecting Coreg over AstraZeneca's Toprol-XL.

London shares up midday; Alliance Boots up on M&A news; Wall ...  -  Mar 12, 2007
Forbes,Sanford Bernstein said patent risks for its Nexium, Seroquel, and Toprol-XL drugs were likely to take centre stage, and AZN is at risk of being de-rated to

KV Pharmaceutical Reports Preliminary Record Revenues for Fiscal ...  -  Feb 7, 2007
Yahoo! News (press release)To that end, we are awaiting approval, yet this fiscal year, of our multiple strength applications for Metoprolol Succinate (Toprol-XL® - AstraZeneca),

AstraZeneca to eliminate 3000 jobs by 2010  -  Feb 2, 2007
The News Journal,Its 650 workers package a host of different drugs, including Toprol-XL and Crestor, AstraZeneca's fast-growing cholesterol reducer.

AstraZeneca to cut 3000 jobs worldwide  -  Feb 1, 2007
The News Journal,AstraZeneca’s US Toprol-XL patent expires in September, but last January, a federal district court judge in Missouri ruled against the company in a patent

People's Pharmacy: Toprol could ease migraines  -  Feb 10, 2007
Bryan College Station Eagle,Dear People's Pharmacy: I am a 40-year-old man taking Toprol-XL for high blood pressure and Crestor for high cholesterol. Before taking Toprol, I suffered

AstraZeneca to Cut 3000 Jobs on Generic Competition (Update5)  -  Feb 1, 2007
BloombergAstraZeneca is trimming jobs as sales of its Toprol-XL hypertension drug decline because of competition from copycat versions. The company spent almost $2

AstraZeneca to Cut 3000 Jobs to Reduce Costs (Update2)  -  Feb 1, 2007
BloombergAstraZeneca is eliminating jobs as sales of its Toprol-XL hypertension drug decline because of competition from generic versions. The company spent almost

AstraZeneca FY broadly in line; 2007 guidance falls short of ...  -  Feb 1, 2007
Forbes,The 2007 outlook excludes any remaining sales of heart drug Toprol XL this year following the launch of cheaper copycat versions in November.

AstraZeneca FY broadly in line; 2007 guidance falls short of ...  -  Feb 1, 2007
Forbes,The bulk of the reduced target relates to lost annual earnings of some 1.5 bln usd from heart drug Toprol XL this year, following the launch of cheaper

3000 jobs go as AstraZeneca faces up to future challenges - 02/02/2007  -  Feb 2, 2007
Pharma Times (subscription),Blood pressure drug Toprol XL (metoprolol), sold as Seloken in some markets, slipped 16% to $387 million and this slide is going to get much worse,

OUTLOOK AstraZeneca FY EPS seen advancing 33 pct; 2007 guidance key  -  Jan 31, 2007
Euro2day,Given an impending rise in spending on research and development, and the entry of generic competition for heart drug Toprol XL, some analysts reckon profit

AstraZeneca Ads Help Crestor Outpace Pfizer's Lipitor (Update4)  -  Jan 30, 2007
Bloomberg...``They're shifting around ad spend and taking it off other things like Nexium -- and they will have saved some on Toprol-XL as there's no point in promoting

Street likes AstraZeneca  -  Feb 5, 2007
Monsters and Critics.com,Seroquel and Crestor should continue to fare well in the year ahead, but Toprol XL and Nexium may feel the impact of generic competition.

AstraZeneca joins Big Pharma jobs cull with plan to axe 3000  -  Feb 1, 2007
Independent,AstraZeneca is to slash 3000 jobs after battling competition from generic manufacturers for its key heart drug Toprol XL.

Life is Good Launches Free Prescription Plan  -  Feb 20, 2007
PR Web (press release),Zocor, Advair, Celebrex, Zoloft, Lisinopril, Norvasc, Premarin, Actonel, Plavix, Atenolol, Toprol XL, Bextra, Diovan, Effexor, Pravachol and many more.

AstraZeneca Seeks a Stronger Pipeline  -  Feb 1, 2007
BusinessWeekIts Toprol XL drug for hypertension is facing stiff competition, particularly in the US, where sales of the medication declined 20% in the period.

UPDATE 5-AstraZeneca to cut 3000 jobs as tough times loom  -  Feb 1, 2007
Reuters.uk,For 2007, it forecast EPS of $3.80 to $4.05, excluding US sales of heart drug Toprol XL, which now has generic rivals. This compares with a figure of $3.36

AstraZeneca to cut 3000 jobs  -  Feb 1, 2007
Reuters.uk,For 2007, it forecasts earnings of $3.80 to $4.05 a share, excluding US sales of heart drug Toprol XL, which is facing generic competition.

Astrazeneca cuts jobs to boost growth  -  Feb 1, 2007
Financial Times,The earnings range excluded any contribution from US sales of Toprol XL its hypertension drug. It recently faced the launch of generic versions of the drug

AstraZeneca Firing 3000  -  Feb 1, 2007
TheStreet.comThe company said it expects to make $3.80 to $4.05 for 2007, excluding any contributions from sales of its Toprol-XL product in the US The hypertension drug

AstraZeneca in £410m bid to lift drugs pipeline  -  Jan 31, 2007
Independent,Nexium and its antipsychotic drug Seroquel have both received patent challenges and a copycat version of its heart drug Toprol XL has been launched.

AstraZeneca posts robust 4Q results; to buy biotechnology firm  -  Feb 1, 2007
newratings.comThe pharmaceutical giant guided to earnings of $3.80-$4.05 per share for 2007, with the figure excluding the contribution from Toprol-XL and charges related

(Adds further detail)  -  Feb 1, 2007
ABCmoney.co.uk,Expectations of earnings per share in the 3.80-4.05 usd range excludes any sales of Toprol XL, a heart drug which is facing competition from newly-released

AstraZeneca to cut 3000 job worldwide  -  Feb 1, 2007
The News Journal,...and faces competition from generic drugmakers to Toprol-XL, its high blood pressure drug, which lost US patent protection in a court ruling last year.

AstraZeneca trades in line, 3000 jobs to go  -  Feb 1, 2007
ShareCast,The forecast excludes US sales of heart drug Toprol XL and any one-off costs associated with productivity initiatives. “In 2006, AstraZeneca reported

Thursday preview: AstraZeneca, Royal Dutch Shell  -  Jan 31, 2007
ShareCast,...for 2006 would come in at the lower end of its $3.85 to $3.95 forecast range following the launch of a generic version of its heart drug Toprol XL.

QuitPak enters pilot study  -  Feb 13, 2007
In-PharmaTechnologist.com,...that has demonstrated in vitro equivalency with AstraZeneca's Toprol XL (metoprolol succinate) in the US and Beloc-ZOK (metoprolol tartrate) in Europe.

UPDATE 1-KV Pharma says Q3 earnings rise; to delay filing  -  Feb 7, 2007
ReutersL: Quote, Profile , Research) heart drug Toprol XL, said its R&D expenses for the rest of the fiscal year could rise on the timing of various clinical

KV Pharmaceutical Reports Preliminary Record Revenues for Fiscal ...  -  Feb 7, 2007
PharmaLive.com (press release),To that end, we are awaiting approval, yet this fiscal year, of our multiple strength applications for Metoprolol Succinate (Toprol-XL(R) - AstraZeneca),

Business Notebook  -  Feb 2, 2007
Boston Globe,...as the UK drug maker reduces expenses to counter competition from generic versions of its best-selling blood pressure medicine Toprol XL.

AstraZeneca posts strong Q4, cuts 3000 jobs  -  Feb 1, 2007
Toronto Star,...euro43.96) on the London Stock Exchange as analysts welcomed the cost-cutting strategy and noted that the 2007 guidance excluded US sales of Toprol XL,

AstraZeneca Fourth-Quarter Net Rises 17% on Seroquel (Update1)  -  Feb 1, 2007
BloombergIn the fourth quarter, the company delayed development of an experimental sepsis treatment and its Toprol-XL for hypertension started facing generic

Euroshares outlook - higher after Wall St gains, earnings news to ...  -  Jan 31, 2007
Forbes,But given the impending rise in spending on research and development, and the entry of generic competition for heart drug Toprol XL, some analysts reckon

Astra to cut 3000 jobs  -  Feb 2, 2007
Manchester Evening News,The forecasts for 2007 excluded any contribution in the US from Toprol-XL, the hypertension drug which is facing generic competition.

AstraZeneca to lay off 3000 over three years  -  Feb 2, 2007
Philadelphia Inquirer,The cuts were forced by weak projections and new generic competition for its heart drug Toprol XL. AstraZeneca is also struggling to replenish its research

Worries in pipeline dampen strong results for drugs firms  -  Jan 31, 2007
Guardian Unlimited,AstraZeneca lost its patent for its heart drug Toprol-XL - in its 25mg dose - last November, and the overall patent for the other doses is due to expire

AstraZeneca to shed 3000 jobs  -  Feb 1, 2007
This is Money,The forecasts for 2007 excluded any contribution in the US from Toprol-XL, the company's hypertension drug which is facing generic competition.

Par Pharmaceutical begins shipment of generic Toprol-XL  -  Dec 22, 2006
Therapeutics Daily (subscription) (press release),Toprol-XL has been formulated to provide a controlled and predictable release of metoprolol for once-daily administration. Annual US sales of Toprol-XL 25

Despite dangers, doctors still prescribe quinine sulfate for ...  -  Jan 14, 2007
Houston Chronicle,Q: I am a 40-year-old male taking Toprol-XL for high blood pressure and Crestor for high cholesterol. Prior to starting on Toprol, I suffered from frequent

Save on prescription drugs  -  Jan 15, 2007
Deseret News,Five blockbuster drugs — Flonase, Pravachol, Toprol-XL, Zocor and Zoloft — went generic in 2006, and eight more pharmaceutical superstars are expected to

CBO faults medicare drug plan  -  Jan 11, 2007
The Westfall Weekly News,For instance, the lowest VA price for a year‘s treatment of Toprol XL, a beta blocker, was $250. The lowest price charged by the largest of the private

BUY ALTACE, Altace Online, Altace Cheap  -  Dec 25, 2006
Indymedia Colombia,Ayerst and King will relaunch Altace in early November altace toprol xl with over psvt altace 2000 sales representatives. ALTACE is indicated for the

CBO says government negotiations wouldn't save money  -  Jan 11, 2007
San Diego Union Tribune,For instance, the lowest VA price for a year's treatment of Toprol XL, a beta blocker, was $250. The lowest price charged by the largest of the private

New Report Shows Medicare Drug Plan Prices Are 58 Percent Higher ...  -  Jan 10, 2007
All American Patriots (press release),For Toprol XL (100 mg), a beta blocker, the VA price was $250.06, and the lowest Part D plan price was $395.52—a difference of $145.46, or 58 percent.

Drugs May Prolong Life After Heart Attack  -  Jan 9, 2007
CBS News,Beta-blockers include such drugs as Coreg and Toprol-XL. They help the heart relax and slow heart rate, boosting the heart's pumping ability over time.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional